Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy

Stopped Participant enrollment is much delayed. The whole design needs to be revised.

Conditions

• Recurrent Vestibulopathy

Interventions

• DRUG: Renexin (cilostazol 100mg + gingko biloba extract 80 mg)
• DRUG: Placebo

Sponsor

Jong Woo Chung

Collaborators

• [object Object]
• [object Object]